Current Concepts on the Pathogenesis of Systemic Sclerosis
| dc.rights.license | open | en_US |
| hal.structure.identifier | Immunology from Concept and Experiments to Translation = Immunologie Conceptuelle, Expérimentale et Translationnelle [ImmunoConcept] | |
| dc.contributor.author | TRUCHETET, Marie Elise | |
| dc.contributor.author | BREMBILLA, N.C. | |
| dc.contributor.author | CHIZZOLINI, C. | |
| dc.date.accessioned | 2022-11-14T14:34:19Z | |
| dc.date.available | 2022-11-14T14:34:19Z | |
| dc.date.issued | 2021-09-06 | |
| dc.identifier.issn | 1559-0267 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/170255 | |
| dc.description.abstractEn | From the clinical standpoint, systemic sclerosis (SSc) is characterized by skin and internal organ fibrosis, diffuse fibroproliferative vascular modifications, and autoimmunity. Clinical presentation and course are highly heterogenous and life expectancy variably affected mostly dependent on lung and heart involvement. SSc touches more women than men with differences in disease severity and environmental exposure. Pathogenetic events originate from altered homeostasis favored by genetic predisposition, environmental cues and a variety of endogenous and exogenous triggers. Epigenetic modifications modulate SSc pathogenesis which strikingly associate profound immune-inflammatory dysregulation, abnormal endothelial cell behavior, and cell trans-differentiation into myofibroblasts. SSc myofibroblasts show enhanced survival and enhanced extracellular matrix deposition presenting altered structure and altered physicochemical properties. Additional cell types of likely pathogenic importance are pericytes, platelets, and keratinocytes in conjunction with their relationship with vessel wall cells and fibroblasts. In SSc, the profibrotic milieu is favored by cell signaling initiated in the one hand by transforming growth factor-beta and related cytokines and in the other hand by innate and adaptive type 2 immune responses. Radical oxygen species and invariant receptors sensing danger participate to altered cell behavior. Conventional and SSc-specific T cell subsets modulate both fibroblasts as well as endothelial cell dysfunction. Beside autoantibodies directed against ubiquitous antigens important for enhanced clinical classification, antigen-specific agonistic autoantibodies may have a pathogenic role. Recent studies based on single-cell RNAseq and multi-omics approaches are revealing unforeseen heterogeneity in SSc cell differentiation and functional states. Advances in system biology applied to the wealth of data generated by unbiased screening are allowing to subgroup patients based on distinct pathogenic mechanisms. Deciphering heterogeneity in pathogenic mechanisms will pave the way to highly needed personalized therapeutic approaches. | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.subject.en | Fibrosis | |
| dc.subject.en | Immune responses | |
| dc.subject.en | Inflammation | |
| dc.subject.en | Pathogenesis | |
| dc.subject.en | System biology | |
| dc.subject.en | Systemic sclerosis | |
| dc.title.en | Current Concepts on the Pathogenesis of Systemic Sclerosis | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1007/s12016-021-08889-8 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Immunologie | en_US |
| dc.identifier.pubmed | 34487318 | en_US |
| bordeaux.journal | Clinical Reviews in Allergy & Immunology | en_US |
| bordeaux.hal.laboratories | ImmunoConcEpT - UMR 5164 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | CNRS | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.identifier.funderID | Université de Genève | en_US |
| hal.identifier | hal-03851656 | |
| hal.version | 1 | |
| hal.date.transferred | 2022-11-14T14:34:25Z | |
| hal.export | true | |
| dc.rights.cc | CC BY | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Clinical%20Reviews%20in%20Allergy%20&%20Immunology&rft.date=2021-09-06&rft.eissn=1559-0267&rft.issn=1559-0267&rft.au=TRUCHETET,%20Marie%20Elise&BREMBILLA,%20N.C.&CHIZZOLINI,%20C.&rft.genre=article |
